FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, namely to a monoclonal antibody or a fragment of said antibody, which bind to integrin α7β1, a method for production thereof, as well as a composition containing same. Also disclosed is an isolated nucleic acid encoding said antibody or a fragment of said antibody, as well as a vector and a cell containing said nucleic acid.
EFFECT: invention is effective for treating a disorder or disease associated with muscle dysfunction in a subject.
42 cl, 31 dwg, 13 tbl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTI-αvβ8 ANTIBODIES AND COMPOSITIONS AND THEIR USE | 2019 |
|
RU2812478C2 |
| INTERSPECIES ANTIBODIES TO LATENT TGF-BETA 1 AND METHODS OF USING THEM | 2020 |
|
RU2837609C2 |
| ISOLATED ALTERNATIVE INTRACELLULAR SIGNALLING DOMAIN OF CHIMERIC ANTIGEN RECEPTOR AND CHIMERIC ANTIGEN RECEPTOR INCLUDING IT | 2019 |
|
RU2742000C2 |
| ANTIBODIES AGAINST SIGNAL-REGULATORY ALPHA PROTEIN AND THEIR APPLICATION METHODS | 2017 |
|
RU2771964C2 |
| ENGINEERED pH-DEPENDENT ANTI-CD3 ANTIBODIES, AS WELL AS METHODS FOR PRODUCTION AND USE THEREOF | 2020 |
|
RU2832079C2 |
| COMBINATIONS OF ANTIBODIES TO STAPHYLOCOCCUS AUREUS | 2019 |
|
RU2804815C2 |
| ANTI-IL31 ANTIBODIES FOR VETERINARY USE | 2018 |
|
RU2795485C2 |
| IL4 RECEPTOR ANTIBODIES FOR USE IN VETERINARY SCIENCE | 2019 |
|
RU2837141C2 |
| ANTI-PD-1 ANTIBODIES | 2019 |
|
RU2788095C2 |
| ANTI-CLDN-18.2 ANTIBODY AND USE THEREOF | 2021 |
|
RU2829997C1 |
